Neurofibromas are benign peripheral nerve sheath tumours usually solitary and sporadic, however, there is a strong association with neurofibromatosis type 1 (NF1). These tumours present as a well-defined hypodense mass with minimal or no contrast enhancement on CT. On MRI, they usually are T1 hypointense and T2 hyperintense with heterogeneous contrast enhancement.
Neurofibromas are generally divided into three subtypes 1-8:
- localised neurofibroma
- diffuse cutaneous neurofibroma (superficial)
- plexiform neurofibroma (deep)
Diffuse cutaneous neurofibromas and plexiform neurofibromas are discussed separately, and localised cutaneous neurofibromas are generally not a radiological diagnosis. As such, the remainder of this article is a general discussion focusing on the most common localised intraneural neurofibromas which are by far the most common form of neurofibroma, representing 90% of these lesions 2.
Peak presentation is between 20 and 30 years of age 5 with no sex predilection.
The majority of localised intraneural neurofibromas are solitary and sporadic and not associated with neurofibromatosis type 1. However, when multiple neurofibromas are present (or plexiform neurofibromas) then the diagnosis of NF1 is almost assured.
The clinical presentation of localised intraneural neurofibromas is non-specific and the result of either mass effect on surrounding lesions (or palpable lump) or neurogenic dysfunction.
Localised intraneural neurofibromas are benign neoplasms composed Schwann cells and fibroblasts, containing a rich network of collagen fibres. They are mostly indolent tumours that rarely only undergo malignant transformation into a malignant peripheral nerve sheath tumour (MPNST); this is only really seen in large neurofibromas, and even then it only occurs in 5-10% of tumours 6.
Neurofibromas are therefore considered WHO grade I tumours under the current (2016) WHO classification of CNS tumours 6.
Unlike schwannomas, neurofibromas are not encapsulated and infiltrate between the nerve fascicles. They primarily affect superficial cutaneous nerves, however occasionally affect larger deep-seated nerves.
General imaging features of neurofibromas:
- well-defined hypodense mass
- minimal or no contrast enhancement
- T1: hypointense
- target sign
- fascicular sign
- T1 C+ (Gd): heterogeneous enhancement
Treatment and prognosis
- lesions not associated with NF1
- localised and diffuse lesions may be treated surgically
- however, as neurofibromas infiltrate between nerve fascicles, they are unable to be separated from the parent nerve and complete excision requires the sacrifice of the nerve
- deep-seated lesions are therefore often managed conservatively
- local recurrence after excision is uncommon and malignant transformation is rare 2
- lesions associated with NF1
- due to the multiplicity of lesions, unless debilitating symptoms are present, treatment of patients with NF1 is often non-surgical
- plexiform neurofibromas are particularly difficult to resect, often leading to incomplete resection.
- recurrence after resection is frequent
- plexiform neurofibromas demonstrate a significant potential for malignant transformation
- 1. Laffan EE, Ngan BY, Navarro OM. Pediatric soft-tissue tumors and pseudotumors: MR imaging features with pathologic correlation: part 2. Tumors of fibroblastic/myofibroblastic, so-called fibrohistiocytic, muscular, lymphomatous, neurogenic, hair matrix, and uncertain origin. Radiographics. 29 (4): e36. doi:10.1148/rg.e36 - Pubmed citation
- 2. Murphey MD, Smith WS, Smith SE et-al. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 19 (5): 1253-80. Radiographics (citation) - Pubmed citation
- 3. Dähnert WF. Radiology Review Manual. (2007) ISBN:0781766206. Read it at Google Books - Find it at Amazon
- 4. Cotran RS, Kumar V, Collins T et-al. Robbins pathologic basis of disease. W.B. Saunders Company. (1999) ISBN:072167335X. Read it at Google Books - Find it at Amazon
- 5. Pilavaki M, Chourmouzi D, Kiziridou A et-al. Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review. Eur J Radiol. 2004;52 (3): 229-39. doi:10.1016/j.ejrad.2003.12.001 - Pubmed citation
- 6. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK "WHO Classification of Tumours of the Central Nervous System. 4th Edition Revised" ISBN: 9789283244929
- 7. Hassell DS, Bancroft LW, Kransdorf MJ, Peterson JJ, Berquist TH, Murphey MD, Fanburg-Smith JC. Imaging appearance of diffuse neurofibroma. AJR. American journal of roentgenology. 190 (3): 582-8. doi:10.2214/AJR.07.2589 - Pubmed
- 8. Mark J. Kransdorf, Mark D. Murphey. Imaging of Soft Tissue Tumors. ISBN: 9780781747714